Ubs Asset Management Americas Inc Rx Sight, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 93,382 shares of RXST stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,382
Previous 84,958
9.92%
Holding current value
$1.43 Million
Previous $2.92 Million
19.28%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RXST
# of Institutions
201Shares Held
34.5MCall Options Held
269KPut Options Held
8.5K-
Ra Capital Management, L.P. Boston, MA3.74MShares$57.2 Million1.96% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$36.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$36.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.18MShares$33.4 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$27 Million0.08% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $423M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...